2009
The mysterious steps in carcinogenesis: addendum
Brash D, Cairns J. The mysterious steps in carcinogenesis: addendum. British Journal Of Cancer 2009, 101: 1490-1490. PMID: 19826429, PMCID: PMC2768438, DOI: 10.1038/sj.bjc.6605332.Commentaries, Editorials and LettersThe mysterious steps in carcinogenesis
Brash D, Cairns J. The mysterious steps in carcinogenesis. British Journal Of Cancer 2009, 101: 379-380. PMID: 19638985, PMCID: PMC2720245, DOI: 10.1038/sj.bjc.6605171.Commentaries, Editorials and Letters
2006
Co-Opting Macrophage Traits in Cancer Progression: A Consequence of Tumor Cell Fusion?
Pawelek J, Chakraborty A, Lazova R, Yilmaz Y, Cooper D, Brash D, Handerson T. Co-Opting Macrophage Traits in Cancer Progression: A Consequence of Tumor Cell Fusion? Contributions To Microbiology 2006, 13: 138-155. PMID: 16627963, DOI: 10.1159/000092970.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCell fusionHuman cancersMacrophage traitsWide diversityCancer cellsTumor-associated macrophagesTumor cell fusionsBranched oligosaccharidesMultidrug resistance proteinN-glycansCancer progressionTumor initiationResistance proteinStroma productionTraitsComplex diseasesMultiple rolesCommon traitsHigh expressionGrowth factorNumerous animal tumor modelsImmune evasionDiversityMutagenic actionMost cancers
2002
Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine.
Havre PA, O'Reilly S, McCormick JJ, Brash DE. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine. Cancer Research 2002, 62: 1443-9. PMID: 11888918.Peer-Reviewed Original Research